Frank Yocca

Frank Yocca

Company: BioXcel

Job title: Senior Vice President & Chief Scientific Officer


IGALMI: Sublingual Dexmedetomidine for the Acute Treatment of Agitation in Schizophrenia and Bipolar Disorder 11:45 am

Use of AI for identifying and developing a therapeutic for an underserved indication Overview and key decisions/data in the discovery, formulation and development of IGALMI for treating acute agitation Applying a “Land and Expand” strategy for new indications and broadening commercial opportunities for IGALMIRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.